188 related articles for article (PubMed ID: 7511454)
1. A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase.
Chen S; Deng PS; Bailey JM; Swiderek KM
Protein Sci; 1994 Jan; 3(1):51-7. PubMed ID: 7511454
[TBL] [Abstract][Full Text] [Related]
2. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
3. A site-directed mutagenesis study at Lys-113 of NAD(P)H:quinone-acceptor oxidoreductase: an involvement of Lys-113 in the binding of the flavin adenine dinucleotide prosthetic group.
Tedeschi G; Deng PS; Chen HH; Forrest GL; Massey V; Chen S
Arch Biochem Biophys; 1995 Aug; 321(1):76-82. PubMed ID: 7639539
[TBL] [Abstract][Full Text] [Related]
4. Mouse liver NAD(P)H:quinone acceptor oxidoreductase: protein sequence analysis by tandem mass spectrometry, cDNA cloning, expression in Escherichia coli, and enzyme activity analysis.
Chen S; Clarke PE; Martino PA; Deng PS; Yeh CH; Lee TD; Prochaska HJ; Talalay P
Protein Sci; 1994 Aug; 3(8):1296-304. PubMed ID: 7527260
[TBL] [Abstract][Full Text] [Related]
5. Purification and crystallization of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase by cibacron blue affinity chromatography: identification of a new and potent inhibitor.
Prochaska HJ
Arch Biochem Biophys; 1988 Dec; 267(2):529-38. PubMed ID: 3214167
[TBL] [Abstract][Full Text] [Related]
6. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).
Zhao Q; Yang XL; Holtzclaw WD; Talalay P
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1669-74. PubMed ID: 9050836
[TBL] [Abstract][Full Text] [Related]
7. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of NAD(P)H:quinone acceptor oxidoreductase by flavones: a structure-activity study.
Chen S; Hwang J; Deng PS
Arch Biochem Biophys; 1993 Apr; 302(1):72-7. PubMed ID: 8470908
[TBL] [Abstract][Full Text] [Related]
9. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.
Li R; Bianchet MA; Talalay P; Amzel LM
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8846-50. PubMed ID: 7568029
[TBL] [Abstract][Full Text] [Related]
10. Characterization of FMN-dependent NADH-quinone reductase induced by menadione in Escherichia coli.
Hayashi M; Hasegawa K; Oguni Y; Unemoto T
Biochim Biophys Acta; 1990 Aug; 1035(2):230-6. PubMed ID: 2118386
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
Cavelier G; Amzel LM
Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
[TBL] [Abstract][Full Text] [Related]
12. Roles of histidine-194, aspartate-163, and a glycine-rich sequence of NAD(P)H:quinone oxidoreductase in the interaction with nicotinamide coenzymes.
Cui K; Ma Q; Lu AY; Yang CS
Arch Biochem Biophys; 1995 Nov; 323(2):265-73. PubMed ID: 7487087
[TBL] [Abstract][Full Text] [Related]
13. Suggested mechanism for the modulation of the activity of NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by menadione: interpretation of the effect of menadione on 5'-[p-(Fluorosulfonyl)benzoyl]adenosine labeling of rat liver NAD(P)H:quinone acceptor oxidoreductase.
Chen S; Liu XF
Mol Pharmacol; 1992 Sep; 42(3):545-48. PubMed ID: 1406605
[TBL] [Abstract][Full Text] [Related]
14. Influence of DT diaphorase on quinone-mediated genotoxicity in human and fish cell lines.
Hasspieler BM; Haffner GD; Adeli K
Mutat Res; 1996 May; 360(1):43-9. PubMed ID: 8657209
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
Friedlos F; Jarman M; Davies LC; Boland MP; Knox RJ
Biochem Pharmacol; 1992 Jul; 44(1):25-31. PubMed ID: 1385952
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places.
Pey AL; Megarity CF; Timson DJ
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30518535
[TBL] [Abstract][Full Text] [Related]
17. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO).
Bianchet MA; Faig M; Amzel LM
Methods Enzymol; 2004; 382():144-74. PubMed ID: 15047101
[No Abstract] [Full Text] [Related]
18. Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling.
Chen S; Wu K; Zhang D; Sherman M; Knox R; Yang CS
Mol Pharmacol; 1999 Aug; 56(2):272-8. PubMed ID: 10419545
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
[TBL] [Abstract][Full Text] [Related]
20. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
Jaiswal AK
Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
